Paul Bradbury/OJO Images via Getty Images Investment Overview This is my third note for Seeking Alpha covering Amneal Pharmaceuticals (NASDAQ:AMRX), the "global pharmaceutical company that develops, manufactures, markets, and distributes a diverse portfolio of essential medicines, including retail generics, injectables, biosimilars and specialty branded pharmaceuticals", according to its 2023 annual report / 10K submission. In March 2022, I gave Amneal stock a "Buy" recommendation after its share price  ...